Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichiro Irie

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Plos One|March 28, 2015
Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trialSeiji Sato, Yoshifumi Saisho, Kinsei Kou, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer systemSatoru Yamada, Akira Shimada, Keiichi Kodama, et al.
Internal Medicine (Tokyo, Japan)|September 20, 2007
Switching from premixed human insulin to premixed insulin lispro: a prospective study comparing the effects on glucose control and quality of lifeSatoru Yamada, Mari Watanabe, Akira Kitaoka, et al.
Diabetology & Metabolic Syndrome|May 27, 2014
Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patientsMasami Tanaka, Risa Nishimura, Takeshi Nishimura, et al.
Internal Medicine (Tokyo, Japan)|January 7, 2014
A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetesYoshifumi Yamada, Junichi Uchida, Hisa Izumi, et al.
Clinical and Experimental Nephrology|January 7, 2023
Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized ratsAyumi Matsui, Ayumi Yoshifuji, Junichiro Irie, et al.
Bioscience of Microbiota, Food and Health|March 1, 2017
L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patientsJunichiro Irie, Yoshihiko Kanno, Rieko Kikuchi, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2010
Comparison of oxidative stress markers in type 2 diabetes: basal bolus therapy versus twice daily premixed insulin analogsMasaki Sakamoto, Gaku Inoue, Kaoru Tsuyusaki, et al.
Plos One|April 27, 2018
Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed miceJunki Miyamoto, Keita Watanabe, Satsuki Taira, et al.
Clinical Drug Investigation|November 6, 2009
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary careKen Yajima, Akira Shimada, Hiroshi Hirose, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Plos One|March 28, 2015
Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trialSeiji Sato, Yoshifumi Saisho, Kinsei Kou, et al.
Annals of the New York Academy of Sciences|December 18, 2003
Relationship between beta cell mass of NOD donors and diabetes development of NOD-scid recipients in adoptive transfer systemSatoru Yamada, Akira Shimada, Keiichi Kodama, et al.
Internal Medicine (Tokyo, Japan)|September 20, 2007
Switching from premixed human insulin to premixed insulin lispro: a prospective study comparing the effects on glucose control and quality of lifeSatoru Yamada, Mari Watanabe, Akira Kitaoka, et al.
Diabetology & Metabolic Syndrome|May 27, 2014
Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patientsMasami Tanaka, Risa Nishimura, Takeshi Nishimura, et al.
Internal Medicine (Tokyo, Japan)|January 7, 2014
A non-calorie-restricted low-carbohydrate diet is effective as an alternative therapy for patients with type 2 diabetesYoshifumi Yamada, Junichi Uchida, Hisa Izumi, et al.
Clinical and Experimental Nephrology|January 7, 2023
Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized ratsAyumi Matsui, Ayumi Yoshifuji, Junichiro Irie, et al.
Bioscience of Microbiota, Food and Health|March 1, 2017
L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patientsJunichiro Irie, Yoshihiko Kanno, Rieko Kikuchi, et al.
Internal Medicine (Tokyo, Japan)|March 2, 2010
Comparison of oxidative stress markers in type 2 diabetes: basal bolus therapy versus twice daily premixed insulin analogsMasaki Sakamoto, Gaku Inoue, Kaoru Tsuyusaki, et al.
Plos One|April 27, 2018
Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed miceJunki Miyamoto, Keita Watanabe, Satsuki Taira, et al.
Clinical Drug Investigation|November 6, 2009
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary careKen Yajima, Akira Shimada, Hiroshi Hirose, et al.
Pageof 8